Key result
~66% of heart failure patients prioritize symptom improvement over survival.
Why the study?
Patient preferences for congestive heart failure therapy outcomes may vary depending on goals of improving symptoms versus survival but have not been extensively investigated.
What are the relative preferences for symptom improvement versus survival among patients with congestive heart failure compared to matched controls?
Comparison
Symptom-sensitive versus survival-sensitive treatment outcome preferences
Design
Prospective full-profile conjoint analysis study
Authors
Loading...
May inform shared decisions on HF symptom vs survival goals; leaves open standardization in practice or trials.
Cross-Sectional (n=98)
No
What are the relative preferences for symptom improvement versus survival among patients with congestive heart failure compared to matched controls?
The majority of symptomatic heart failure patients prioritize improved symptoms over longer survival, highlighting the importance of incorporating patient preferences into therapy design.
Stanek et al. (2000) conducted a cross-sectional in Congestive heart failure (n=98). Congestive heart failure vs. Matched control subjects was evaluated on Importance weights for treatment attributes (tiredness, shortness of breath, depression, and survival). Among heart failure patients, the majority (33 of 50 classified) prioritized symptom improvement over survival, with survival importance weights of 0.18 versus 0.43 (P<0.01) respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: